Related Experiment Video
Updated: Mar 25, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
International Developments in the Care of Familial Hypercholesterolemia: Where Now and Where to Next?
Jing Pang1, Peter J Lansberg, Gerald F Watts
1School of Medicine and Pharmacology, University of Western Australia.
Insights
Familial hypercholesterolemia (FH) care guidelines exist, but systematic screening programs are lacking globally. This study reviews international initiatives to improve FH detection and treatment worldwide.
Area of Science:
- Cardiology
- Genetics
- Public Health
Background:
- International guidelines for familial hypercholesterolemia (FH) care are available.
- These guidelines cover case detection, cascade testing, pediatric protocols, treatment strategies, and apheresis indications.
- Most countries lack systematic FH screening programs for community-based detection and treatment.
Purpose of the Study:
- To provide a comprehensive overview of current and future international initiatives for familial hypercholesterolemia (FH) care.
- To address the gaps in FH detection and treatment at a global level.
Main Methods:
- Review of recent international guidelines and consensus statements on FH care.
- Analysis of current and proposed international initiatives for FH screening and management.
Main Results:
- Agreement exists on various aspects of FH care, including detection, testing, treatment, and apheresis.
- Significant disparities persist in the implementation of systematic FH screening programs worldwide.
Conclusions:
- Despite established guidelines, global implementation of FH care remains insufficient.
- International initiatives are crucial for bridging the gaps in FH detection and treatment, improving patient outcomes.
Abstract:
Several international guidelines and consensus statements have recently been published on the care of familial hypercholesterolemia (FH)(1-3)). They agree on approaches to case detection and cascade testing, protocols in children, lifestyle and drug treatment strategies, and indications for lipoprotein apheresis. However, most countries in the world still do not have integrated, systematic FH screening programs to adequately detect and treat cases in the community. This study provides a comprehensive overview of recent and future international initiatives for closing the gaps in the care of FH.
Related Concept Videos
Atherosclerosis III: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cholesterol: Significance and Regulation
Considering cholesterol and...
Atherosclerosis IV: Nursing Management
Coronary Artery Disease IV: Preventive Measures
Lipids: Dietary Sources and Requirements

